Assessing genetic factors, presenting symptoms, and comorbidities in ovarian cancer diagnosis and survival: a retrospective study
Ko, S.; Demirchian, M.; Diaz Miranda, E.; Goldenberg, C.; Krell, K.; Parry, E.; Hunter, M.; Brennaman, L.; Hull, A.; Voth, C.; Lei, L.
Show abstract
Objective: The purpose of this study is to determine how family history of cancer, genetic mutations, presenting symptoms, and comorbidity burden collectively influence cancer outcomes in patients with epithelial ovarian cancer. Methods: A retrospective analysis was conducted on all patients with epithelial ovarian cancer treated at the University of Missouri and Ellis Fischel Cancer Center between 2008 and 2024. Patient charts were reviewed for histological subtypes, stage of cancer, status of metastasis, CA-125 values, presenting symptoms, comorbidities, family history of cancer, genetic mutations, and survival outcome. Cox regression and association analyses were performed. Results: In this cohort of patients, comorbidities and genetic mutations did not influence ovarian cancer survival. While histological subtypes, CA-125 levels, and cancer stage remained strongly associated with survival. Significant associations were observed between certain presenting symptoms and cancer histological subtype, a family history of breast cancer, stage of cancer at diagnosis, the status of metastasis, and CA-125 levels. Conclusion: Comorbidities and genetic mutations were not significantly associated with ovarian cancer survival. Presenting symptoms were associated with several clinical and pathological variables linked to ovarian cancer diagnosis.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Impact of BRCA mutation status on tumor infiltrating lymphocytes (TILs), response to treatment, and prognosis in breast cancer patients treated with neoadjuvant chemotherapy. 93%
- Molecular Heterogeneity in Early-Onset Colorectal Cancer: Pathway-Specific Insights in High-Risk Populations 93%
- Hormone Receptor-status Prediction in Breast Cancer Using Gene Expression Profiles and Their Macroscopic Landscape 93%
Similar papers in this journal
- Squamous differentiation portends poor prognosis in low and intermediate-risk endometrioid endometrial cancer. 94%
- Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: validation on a cohort of BC patients treated by neoadjuvant chemotherapy. 92%
- Associations between genetic HPV 16 diversity and cervical cancer prognosis 92%
Similar papers in this journal
- The role of KPNA2 mutations in breast cancer prognosis: A survey of publicly available databases 92%
- Risk-Reducing Salpingectomy: Considerations from an OBGYN Perspective 92%
- Effectiveness of educational intervention on breast cancer knowledge and breast self-examination among female university students in Bangladesh: a pre-post quasi-experimental one group study 91%
Similar papers in this journal
- Detecting PI3K and TP53 Pathway Disruptions in Early-Onset Colorectal Cancer Among Hispanic/Latino Patients 93%
- Circulating serum miRNAs predict response to platinum chemotherapy in high-grade serous ovarian cancer 90%
- Sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors on new-onset overall cancer in type 2 diabetes mellitus: a population-based study 90%
Similar papers in this journal
- Pan-cancer analyses of the associations between 109 pre-existing conditions and cancer treatment patterns across 19 adult cancers 92%
- Genetic Risk Factors for Colorectal Cancer in Multiethnic Indonesians 91%
- Disparities in outcomes among patients diagnosed with cancer associated with emergency department visits 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.